NCT01005797: Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers |
|
|
| Completed | 1 | 38 | US | Panobinostat (LBH589), Sorafenib | Medical University of South Carolina, Novartis Pharmaceuticals | Renal Cancer, Non Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma | 03/14 | 01/17 | | |
| Terminated | 1 | 4 | US | Marizomib, salinosporamide A, salinosporin A, Panobinostat, Farydak | Dana-Farber Cancer Institute, Celgene, Secura Bio, Inc. | Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent, Pediatric Cancer, Pediatric Brain Tumor, Diffuse Glioma | 02/24 | 02/24 | | |
